Celexib 100- EZS and Insulin aspart, recombinant Subcutaneous
Determining the interaction of Celexib 100- EZS and Insulin aspart, recombinant Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: celecoxib
Brand name: Celebrex, Celebrex
Synonyms: Celecoxib
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Celexib 100- EZS-Insulin degludec
- Celexib 100- EZS-Insulin Degludec (U-100) Prefilled Pens
- Celexib 100- EZS-Insulin Degludec (U-100) Vials
- Celexib 100- EZS-Insulin Degludec (U-200) Prefilled Pens
- Celexib 100- EZS-Insulin degludec and liraglutide
- Celexib 100- EZS-Insulin degludec and liraglutide Subcutaneous
- Insulin aspart, recombinant Subcutaneous-Cellcept
- Insulin aspart, recombinant Subcutaneous-CellCept (Mycophenolate Mofetil Capsules)
- Insulin aspart, recombinant Subcutaneous-CellCept (Mycophenolate Mofetil Injection Solution)
- Insulin aspart, recombinant Subcutaneous-CellCept (Mycophenolate Mofetil Oral Suspension)
- Insulin aspart, recombinant Subcutaneous-CellCept (Mycophenolate Mofetil Tablets)
- Insulin aspart, recombinant Subcutaneous-Cellcept Oral